# Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

> **NCT01865474** · PHASE4 · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 122 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** DLBS1033
- **DRUG:** placebo tablet of DLBS1033

## Key facts

- **NCT ID:** NCT01865474
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2016-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01865474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01865474, "Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01865474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*